China has been talking up its markets, and that’s lifting all boats this morning, with Wall Street poised for a strong start ahead of what’s expected to be the first Fed rate hike in more than three years.
For starters, investors in the U.S. have a huge selection of innovative companies to choose from, with active managers often better placed to generate alpha as many of those stocks go overlooked by Wall Street. Maravai Lifesciences MRVI, +2.21% is also on his list, as the biopharma group recently spurned a German bid. “t is well-positioned to take advantage of the massive influx of interest and investment flowing into the mRNA area as well as growth in the cell and gene therapy space more broadly,” he said.
Ahead of the Fed outcome and news conference with Chair Jerome Powell, data showed retail sales rising 0.3%, falling short of expectations for a 0.4% gain in February. Import prices cooled slightly, gaining 1.4% in that month from 1.9% previously. Still to come are a home builders’ index and revised business inventories.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: MarketWatch - 🏆 3. / 97 더 많은 것을 읽으십시오 »